Is COMPASS Pathways (NASDAQ:CMPS) Weighed On By Its Debt Load?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' When we think about how risky a company is, we always like to look at its use of debt, since debt overload can lead to ruin. As with many other companies COMPASS Pathways plc (NASDAQ:CMPS) makes use of debt. But the more important question is: how much risk is that debt creating?

Advertisement

When Is Debt Dangerous?

Generally speaking, debt only becomes a real problem when a company can't easily pay it off, either by raising capital or with its own cash flow. Part and parcel of capitalism is the process of 'creative destruction' where failed businesses are mercilessly liquidated by their bankers. While that is not too common, we often do see indebted companies permanently diluting shareholders because lenders force them to raise capital at a distressed price. Of course, the upside of debt is that it often represents cheap capital, especially when it replaces dilution in a company with the ability to reinvest at high rates of return. When we examine debt levels, we first consider both cash and debt levels, together.

How Much Debt Does COMPASS Pathways Carry?

You can click the graphic below for the historical numbers, but it shows that as of September 2025 COMPASS Pathways had US$31.3m of debt, an increase on US$29.8m, over one year. However, it does have US$185.9m in cash offsetting this, leading to net cash of US$154.7m.

debt-equity-history-analysis
NasdaqGS:CMPS Debt to Equity History December 8th 2025

How Strong Is COMPASS Pathways' Balance Sheet?

The latest balance sheet data shows that COMPASS Pathways had liabilities of US$197.5m due within a year, and liabilities of US$20.6m falling due after that. Offsetting this, it had US$185.9m in cash and US$40.3m in receivables that were due within 12 months. So it can boast US$8.23m more liquid assets than total liabilities.

This state of affairs indicates that COMPASS Pathways' balance sheet looks quite solid, as its total liabilities are just about equal to its liquid assets. So while it's hard to imagine that the US$558.8m company is struggling for cash, we still think it's worth monitoring its balance sheet. Succinctly put, COMPASS Pathways boasts net cash, so it's fair to say it does not have a heavy debt load! There's no doubt that we learn most about debt from the balance sheet. But ultimately the future profitability of the business will decide if COMPASS Pathways can strengthen its balance sheet over time. So if you want to see what the professionals think, you might find this free report on analyst profit forecasts to be interesting.

View our latest analysis for COMPASS Pathways

Since COMPASS Pathways doesn't have significant operating revenue, shareholders may be hoping it comes up with a great new product, before it runs out of money.

So How Risky Is COMPASS Pathways?

Statistically speaking companies that lose money are riskier than those that make money. And we do note that COMPASS Pathways had an earnings before interest and tax (EBIT) loss, over the last year. And over the same period it saw negative free cash outflow of US$161m and booked a US$237m accounting loss. However, it has net cash of US$154.7m, so it has a bit of time before it will need more capital. Overall, its balance sheet doesn't seem overly risky, at the moment, but we're always cautious until we see the positive free cash flow. When analysing debt levels, the balance sheet is the obvious place to start. But ultimately, every company can contain risks that exist outside of the balance sheet. These risks can be hard to spot. Every company has them, and we've spotted 3 warning signs for COMPASS Pathways (of which 2 are a bit concerning!) you should know about.

If you're interested in investing in businesses that can grow profits without the burden of debt, then check out this free list of growing businesses that have net cash on the balance sheet.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

MI
mitchell_lawler
mitchell_lawler

Druckenmiller says cheap money's days are numbered. Boring, self-funding companies could be the opportunity.

Druckenmiller says cheap money's days are numbered. Boring, self-funding companies could be the opportunity. cover
1311
DE
devon_jd150

Leverage on its own is close to useless as a screen right now, because so much corporate debt was termed out at 2 to 3% and has not repriced. A business at three times leverage with nothing due until 2031 is in a completely different position from the same ratio rolling next year. Screen on weighted average maturity and the schedule behind it.

LE
LeverageIsLovely

In my view, Insurance companies are best positioned for this.

Mitchell Lawler

Which payment stocks actually get paid?

Which payment stocks actually get paid? cover
Every new payment app was supposed to kill Visa and Mastercard. Instead, they got bigger. So what does that mean for the payment stocks on your radar?
32

About NasdaqGS:CMPS

COMPASS Pathways

Operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States.

Excellent balance sheet with low risk.

Similar Companies

Advertisement

Weekly Picks

RI
Rick_Orford
FJET logo
Rick_Orford on Starfighters Space ·

The 1960s Fighter Jet That Could Crack Open a $20 Billion Satellite Market

Fair Value:US$522.8% undervalued
67 users have followed this narrative
4 users have commented on this narrative
11 users have liked this narrative
TR
tripledub
Recommended Voice
META logo
tripledub on Meta Platforms ·

The $135 Billion Bet That Should Make Every Shareholder Nervous

Fair Value:US$5862.7% undervalued
48 users have followed this narrative
3 users have commented on this narrative
34 users have liked this narrative
TA
Talos
Emerging Author
VOYG logo
Talos on Voyager Technologies ·

The "Landlord of Orbit" – A Deep Value Play Ahead of the Starlab Era

Fair Value:US$385.291.0% undervalued
32 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
IV
Emerging Author
UBER logo
Ivoed on Uber Technologies ·

Uber’s Valuation Depends On Who Captures The Economics Of Driverless Rides

Fair Value:US$11630.7% undervalued
8 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative

Updated Narratives

WO
woodworthfund
KHC logo
woodworthfund on Kraft Heinz ·

Kraft Heinz (KHC): Less Drama, More Ketchup

Fair Value:US$3527.7% undervalued
27 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
LU
LunaRodas
DKS logo
LunaRodas on DICK'S Sporting Goods ·

DKS | DICK'S Sporting Goods: What They Said vs. What They Did

Fair Value:US$112.7710.2% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
PR
prajeeshprathap
MEDP logo
prajeeshprathap on Medpace Holdings ·

Why Medpace Outperforms Competitors in the Mid-Sized Biotech Niche

Fair Value:US$53614.6% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28023.9% undervalued
355 users have followed this narrative
9 users have commented on this narrative
16 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9117.1% overvalued
204 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
KI
AMZN logo
KiwiInvest on Amazon.com ·

Amazon's high growth, high tech segments propel its profits, while traditional segments plod along

Fair Value:US$475.0945.1% undervalued
228 users have followed this narrative
1 users have commented on this narrative
8 users have liked this narrative

Trending Discussion

HA
HarishPK
EVER logo
HarishPK on EverQuote ·

Feedback welcome!

3
|
0
MA
MRNA logo
Madave on Moderna ·

Aged like wine

2
|
0